Skip to main content

GENE THERAPY SHOWS IMPROVEMENT IN VISION FOR CONGENITAL BLINDNESS

 

GENE THERAPY SHOWS IMPROVEMENT IN VISION FOR CONGENITAL BLINDNESS
 

A new gene therapy, ATSN-101, has shown promising results in improving vision and light detection in both adults and children with a rare form of congenital blindness called Leber congenital amaurosis (LCA) 1. This type of LCA is caused by mutations in the GUCY2D gene. The early-phase clinical trial, published in “The Lancet”, involved 15 patients and demonstrated significant improvements, particularly in light detection.


Gene therapy


In this trial, after 12 months of treatment, patients who received the highest dose of the therapy showed improved ability to see finer details. For example, there was an improvement of about 8 letters on an eye test chart, which equates to nearly two lines on the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. While the improvements in visual sharpness (acuity) were modest, the ability to detect light, especially in long-dormant photoreceptors (rods and cones in the retina), was the standout finding.

Dr. Artur Cideciyan, one of the lead researchers, explained that even after decades of dysfunction, the photoreceptors in the patients' eyes began functioning again within 8-10 days after receiving the gene therapy. This suggests that even long-standing congenital conditions might be treatable, as the cells responsible for vision haven't completely lost their ability to function.

Light Detection Improvements

The most exciting part of the study was the significant improvements in light detection. For example, in the dark-adapted full-field stimulus test (FST), which measures the dimmest light detectable in darkness, patients who received the highest dose of the therapy showed significant improvement—some by more than 10,000 times. Six out of the nine high-dose patients had major improvements in their ability to detect light.

Dr. Darius Moshfeghi, a retina specialist, commented on the study, noting that this was the first time gene therapy had shown such a dramatic improvement in vision function for an inherited retinal disease. This finding gives hope for treating other similar diseases, as it shows that photoreceptors can regain function even after being inactive for years.


Congenital blindness


Gene Therapy and the Procedure

ATSN-101 is a gene therapy that uses a recombinant AAV5 vector containing the human GUCY2D gene. This therapy is delivered through surgery where a retina specialist injects the gene vector under the retina. Three doses were tested in the trial, and after seeing initial improvements, a higher dose was administered to six additional patients (three adults and three children).

Safety Concerns and Learning Curve

Although the therapy showed promise, there were some side effects related to the surgery. The study reported 68 treatment-related adverse events, including eight patients experiencing low eye pressure (hypotony) and complications such as macular holes and retinal detachment in a few patients. While these issues were treatable, they highlight the need for improved surgical techniques and learning curves in administering the therapy.

Overall, the results are very encouraging for the future of gene therapy in treating congenital blindness and other inherited retinal diseases, offering hope that dormant photoreceptors can be revived to restore vision.





Labels:

Comments

Post a Comment

Popular posts from this blog

Chronic neck pain

  Chronic Neck Pain: A Primary Care Approach Neck pain bahut hi common hai, aur ise hum teen main types mein divide karte hain: 1. Mechanical Neck Pain Ye sabse zyada commonly dekhi jaane wali neck pain hai jo primary care centre mein aati hai. Patients ko generally localized neck pain hota hai jo kisi aur jagah radiate nahi karta. Zyada tar ye pain neck ke center mein hota hai. Symptoms: Localized pain jo neurological deficits ke bina hota hai, jaise weakness ya numbness nahi hoti. Agar aap us jagah ko press karte ho jaha "ouch" feel hota hai, toh wohi area problematic hota hai. Etiology: Exact cause clear nahi hota, lekin myofascial ya musculoskeletal strain se related hota hai. Management: Ye pain time ke sath apne aap theek ho jaata hai, chahe aap koi intervention karein ya na karein. Common treatments mein NSAIDs (painkillers), physical therapy, aur massage include hain. Physical therapy helpful ho sakti hai taaki patient apni posture aur movement ko sudha
Post a Comment
Read more

GENE THERAPY SE DIKHAYI DENE LAGI BEHTAR VISION CONGENITAL BLINDNESS MEIN

  GENE THERAPY SE DIKHAYI DENE LAGI BEHTAR VISION CONGENITAL BLINDNESS MEIN   Ek naye gene therapy, ATSN-101, ne rare congenital blindness ke ek type, Leber congenital amaurosis (LCA) 1, se peedit bade aur bacchon mein roshni ko mehsoos karne aur vision ko behtar banane ke promising results dikhaye hain. Ye LCA, GUCY2D gene mein mutation ke kaaran hoti hai. “The Lancet”mein chhapi ek early-phase clinical trial mein 15 patients ko shaamil kiya gaya aur roshni ko mehsoos karne mein khaas sudhar dekha gaya. Is trial ke dauran, 12 mahine ke ilaj ke baad, jinhonne therapy ka sabse highest dose liya unmein nazar ke bareek tafseel (fine details) dekhne ki kshamata mein sudhar dikha. Example ke taur par, patients ne eye test chart par lagbhag 8 letters behtar dekhe, jo ETDRS chart ke lagbhag 2 lines ke barabar hai. Halanki nazar ki tez kshamata (acuity) mein sudhar chhote the, lekin roshni ko mehsoos karne ki kshamata, khaaskar retine ke rods aur cones mein, sabse khaas baat thi. Dr. A
Post a Comment
Read more

Sweet syndrome (Introduction, Types, Pathophysiology)

  Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) Introduction Sweet Syndrome (SS), ya acute febrile neutrophilic dermatosis, ko pehli baar Robert Douglas Sweet ne 1964 mein describe kiya tha. Ye ek reactive process hai jo achanak se tender, red-to-purple papules aur nodules ke saath hota hai, jo aksar plaques banate hain. Ye lesions zyadatar upper extremities, face, ya neck par hote hain. Is dermatologic condition ke saath fever aur elevated neutrophil levels (peripheral neutrophilia) bhi dekhe jaate hain. Sweet syndrome ko teen types mein categorize kiya gaya hai based on underlying cause: 1. Classic ya Idiopathic Sweet Syndrome Ye sabse common form hai, jo predominantly young women ko affect karta hai aur aksar mild respiratory illness ke baad hota hai. Iska association pregnancy, inflammatory bowel disease (IBD), vaccinations, inflammatory conditions, aur infections se bhi ho sakta hai. 2. Malignancy-Associated Sweet Syndrome   Ye form underlying malignancy ke
Post a Comment
Read more